Supplement Library
INDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s12 | Copyright © December 2023
Background: Prurigo Nodularis (PN) is a relatively rare chronic inflammatory skin disease characterized by firm pruritic nodules. PN is associated with significantly increased ra...
Read MoreINDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s6 | Copyright © December 2023
Prurigo nodularis (PN) is a quintessential neurocutaneous condition characterized by neural sensitization and intractable itch leading to intense scratching. This causes the formation of nodules ...
Read MoreINDIVIDUAL ARTICLE: New Horizons in Our Understanding of Prurigo Nodularis and Its Management
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF365502s4 | Copyright © December 2023
FULL SUPPLEMENT: Real-World Experience Integrating Ceramide-Containing Cleansers And Moisturizers Into Prescription Treatment and Maintenance for Pediatric Patients With Atopic Dermatitis
December 2023 | Volume 22 | Issue 12 | Department | SF389716s2 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposition....
Read MoreINDIVIDUAL ARTICLE: Pediatric Atopic Dermatitis Patient Cases Integrating Ceramides-Containing Cleansers and Moisturizers into Prescription Treatment and Maintenance Approaches
December 2023 | Volume 22 | Issue 12 | Supplement Individual Articles | SF389716s3 | Copyright © December 2023
Introduction: Atopic dermatitis (AD) is a common, chronic recurrent disorder typically starting in infancy and early childhood and associated with pruritus and genetic predisposi...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (NECOM) 3: A Practical Algorithm for Acute Radiation Dermatitis Management for Cancer Patients Receiving Radiation Therapy
November 2023 | Volume 22 | Issue 11 | Department | SF400354s1 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may...
Read MoreFULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM) III: A Multidisciplinary-Guided Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events in Cancer Patients
November 2023 | Volume 22 | Issue 11 | Department | SF389716s1 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreINDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF389716s4 | Copyright © November 2023
Background: In 2023, nearly 2 million patients will be diagnosed with cancer in the United States and at least 40% will be eligible for treatment with an immune checkpoint inhibi...
Read MoreINDIVIDUAL ARTICLE: Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | SF378719s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read MoreINDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis
November 2023 | Volume 22 | Issue 11 | Supplement Individual Articles | SF400354s3 | Copyright © November 2023
Background: In the Nordic European countries in 2020, cancer diagnoses accounted for 175,925 patients. About 50% of cancer patients receive radiation therapy (RT), which may lead...
Read MoreFULL SUPPLEMENT: The Importance of Skincare in Eczema: A Novel Over-the-Counter Routine Improves Signs and Symptoms in Patients with Eczema
October 2023 | Volume 22 | Issue 10 | Department | SF388641s1 | Copyright © October 2023
In the United States, the National Eczema Association estimates that 1 out of every 10 people have some form of eczema over their lifetime. As any dermatologist can attest, managing patients with...
Read MoreFULL SUPPLEMENT: Brodalumab: Five Years of Real-World Safety and Efficiency
October 2023 | Volume 22 | Issue 10 | Department | SF378632s1 | Copyright © October 2023
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasi...
Read MoreIndividual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s10 | Copyright © October 2023
Background: Study to compare efficacy, tolerability, and patient perception between an over-the-counter itch relief gel (IRG) and itch relief moisturizing cream (IRMC) after a si...
Read MoreIndividual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s21 | Copyright © October 2023
Background: Eczema, or atopic dermatitis (AD), is a chronic relapsing skin disease associated with unpredictable flares of erythema, rash, and pruritus. AD arises from a combinat...
Read MoreIndividual Article: Over-the-Counter Moisturizers Significantly Improve Skin Hydration in Adults With Eczema/Atopy-Prone Skin
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s16 | Copyright © October 2023
Background: Many adults suffer from dry, itchy skin, particularly those with eczema-prone skin. This study evaluated the effects of two over-the-counter (OTC) moisturizing produc...
Read MoreIndividual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF388641s5 | Copyright © October 2023
Background: Eczema (also called atopic dermatitis) is a chronic, relapsing skin disease characterized by erythema, scaling, and pruritus.
Methods: Study 1....
Read MoreIndividual Article: Brodalumab Is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 Update
October 2023 | Volume 22 | Issue 10 | Supplement Individual Articles | SF378632s5 | Copyright © October 2023
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasi...
Read MoreFULL SUPPLEMENT: Optimizing Transungal Efficacy at the Site of the Infection With Efinaconazole
September 2023 | Volume 22 | Issue 9 | Department | SF378719s5 | Copyright © September 2023
Onychomycosis is a prevalent condition affecting the United States and global population. Treatment options are limited, with only 3 topical anti-fungal medications garnering approval in the US w...
Read MoreINDIVIDUAL ARTICLE: Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe
September 2023 | Volume 22 | Issue 9 | Department | SF378719s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter
September 2023 | Volume 22 | Issue 9 | Supplement Individual Articles | s5 | Copyright © September 2023
Topical medications are commonly used to manage mild-to-moderate psoriasis and serve as adjunct therapies used in combination with phototherapy and systemic treatments. Fixed-dose calcipotriene (Cal) ...
Read More